Phone: 1.510.856.5600|info@anthera.com

Press Releases

 
Press Releases
  Date Title and Summary View
Jul 2, 2007
SAN MATEO, CA - July 2, 2007 - Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs for chronic and acute diseases, announced today that enrollment of 200 patients in the phase 2 PLASMA (Phospholipase Levels And Serological Markers of Ath...
Apr 13, 2007
SAN MATEO, CA - April 13, 2007 - Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs for chronic and acute diseases, announced today that enrollment has begun in the company's multi-center phase 2 clinical trial (PLASMA - Phospholipase Levels A...
Mar 20, 2007
San Mateo‚ CA – March 20‚ 2007 – Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs for chronic and acute diseases, announced today the appointment of James E. Pennington, M.D. to the position of Executive Vice President & Chief Medical Officer. Dr...
Mar 8, 2007
San Mateo‚ CA – March 8‚ 2007 – Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs for acute and chronic diseases, announced today the appointment of Drs. Alan Leff, Michael A. Matthay, B. Taylor Thompson, and Stephen Rennard to its Respiratory and Acu...
Feb 13, 2007
San Mateo‚ CA – February 13‚ 2007 – Anthera Pharmaceuticals‚ Inc.‚ a privately held biopharmaceutical company developing anti–inflammatory drugs for chronic and acute diseases‚ announced today the appointment of Dr. David Waters‚ Dr. Robert Rosenson and Dr. Stephen Nicholls to its Card...
Feb 7, 2007
San Mateo‚ CA – February 7‚ 2007 – Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs for chronic and acute diseases, announced today that David D. Waters, MD has joined the company as Cardiovascular Research Fellow. Dr. Waters has over 20 years of exp...
Jan 9, 2007
San Mateo‚ CA – January 9‚ 2007 – Anthera Pharmaceuticals‚ Inc.‚ a privately held biopharmaceutical company developing anti-inflammatory drugs‚ announced today that the U.S. Food and Drug Administration has approved its Investigational New Drug (IND) application for use of its lead compound A-0...
Jan 4, 2007
San Mateo‚ CA – January 4‚ 2007 – Anthera Pharmaceuticals‚ Inc.‚ a privately held biopharmaceutical company developing anti-inflammatory drugs for chronic and acute diseases‚ announced today that the US Food and Drug Administration has approved its Investigational New Drug (IND) application ...
Dec 10, 2006
San Mateo‚ CA – December 10‚ 2006 – After months of hard training, combined with an extraordinary personal effort to raise money for Children’s Hospital Oakland Research Institute (CHORI), Keiko Mitsunobu, Senior Director of Business Development at Anthera Pharmaceuticals, finished the Honolulu marathon...
Sep 13, 2006
San Francisco‚ CA – September 13‚ 2006 – Anthera Pharmaceuticals‚ a specialty pharmaceutical company developing therapies for the treatment of serious inflammatory diseases‚ today announced it closed an initial $36 million in venture financing. The funding was co–led by VantagePoint Venture ...
Page: FirstPrevious ...
19
NextLast
= add release to Briefcase
Print Friendly